Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $8.56 Million |
|---|---|
| Enterprise Value | $-53,469.00 |
| Earnings per Share | $-7.35 |
| Beta | 0.96 |
| Outstanding Shares | 6,679,250 |
| P/E Ratio | -0.4 |
|---|---|
| PEG | -1.09 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -2.99 |
| Debt to Equity | 0.07 |
No data
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 3.53%▼ 1.35% |
|---|---|
| Total Invested | $328,434▼ 20.67% |
| Investors Holding | 13▼ 4.00% |
Headquartered in Cambridge, Massachusetts, MetaVia Inc. operates as a clinical-stage biotechnology company with a core focus on discovering and commercializing novel pharmaceutical solutions for cardiometabolic disorders. Its leading inv...